Those who have been involved in glioblastoma research will be able to tell you about this condition in particular. For those who don't know, gliomas are seen as not only the most prevalent types of tumors in the brain but the most aggressive, to boot. It's clear that there is more that can be done to help this way of research but what will it entail? It seems as though there should be work done regarding various gene mutations and particular relations that will be seen along with them.
An article on BioNews Texas spoke about how there were a number of new findings related to glioblastoma multiforme, which is something that researchers have focused on and for good reasons. The report said that, in 2013, there are about 23,000 cases of this condition being expected and most patients pass away within 15 months of diagnosis. As you can imagine, there has been work done in order to make better sense of this condition. What has come to the surface as a result of such efforts?
Professor as well as the chair of the Cancer Genome Atlas, Lynda Chin, M.D., spoke about the findings that came about following a sojourn of five years. There has been quite a bit of data that has been uncovered and I think that there are many ways it could be put into practice. Such information has been able to detail such things as genetic mutations, deletions, and what have you. I think that, if such knowledge is put into effect, more effective therapies stand a strong chance of coming about.
I believe that past mutations have to be looked to as well, a point that is supported by organizations along the lines of Voices against Brain Cancer. Keep in mind that there are many individuals who have been involved in the realm of glioblastoma research and they can tell you about the many findings related to genes. The report said that 61 mutated genes have been newly discovered and one of the more interesting points of information had to do with the epidermal growth factor receptor. For those who do not know, the EGFR gene was seen as mutated in 57% of these tumors.
With so much attention being brought to glioblastoma research in general, it is apparent that these particular tumors are some of the most tremendous you can imagine. To me, these growths have so many intricacies that only those who have been trained in the medical field will be able to effectively pinpoint. However, there seems to be common mutations amongst them. With this in mind, I believe that it is clear that potential for greater therapies being made in the future is a factor that will soon be realized.
An article on BioNews Texas spoke about how there were a number of new findings related to glioblastoma multiforme, which is something that researchers have focused on and for good reasons. The report said that, in 2013, there are about 23,000 cases of this condition being expected and most patients pass away within 15 months of diagnosis. As you can imagine, there has been work done in order to make better sense of this condition. What has come to the surface as a result of such efforts?
Professor as well as the chair of the Cancer Genome Atlas, Lynda Chin, M.D., spoke about the findings that came about following a sojourn of five years. There has been quite a bit of data that has been uncovered and I think that there are many ways it could be put into practice. Such information has been able to detail such things as genetic mutations, deletions, and what have you. I think that, if such knowledge is put into effect, more effective therapies stand a strong chance of coming about.
I believe that past mutations have to be looked to as well, a point that is supported by organizations along the lines of Voices against Brain Cancer. Keep in mind that there are many individuals who have been involved in the realm of glioblastoma research and they can tell you about the many findings related to genes. The report said that 61 mutated genes have been newly discovered and one of the more interesting points of information had to do with the epidermal growth factor receptor. For those who do not know, the EGFR gene was seen as mutated in 57% of these tumors.
With so much attention being brought to glioblastoma research in general, it is apparent that these particular tumors are some of the most tremendous you can imagine. To me, these growths have so many intricacies that only those who have been trained in the medical field will be able to effectively pinpoint. However, there seems to be common mutations amongst them. With this in mind, I believe that it is clear that potential for greater therapies being made in the future is a factor that will soon be realized.
About the Author:
Contact Voices Against Brain Cancer if you are searching for more information about glioblastoma research.
0 comments:
Post a Comment